IMPL - Impel Pharma says Chapter 11 bankruptcy possible; down 30%
2023-08-15 18:04:50 ET
More on Impel NeuroPharma
- Impel NeuroPharma Non-GAAP EPS of -$0.97 beats by $0.06, revenue of $5.01M misses by $0.24M
- Impel cut to Neutral at Wedbush on sales outlook for migraine therapy
For further details see:
Impel Pharma says Chapter 11 bankruptcy possible; down 30%